NEW YORK – Bio-Rad Laboratories reported Wednesday after the close of the market that its first quarter revenues increased 3 percent year over year.
For the three months ended March 31, 2020, Bio-Rad reported revenues of $571.6 million compared to $554.0 million a year ago, and well ahead of analysts' expectation for revenues of $554.9 million.
On a currency-neutral basis, Q1 revenues increased 4 percent year over year, the company said.